| Not Yet Recruiting | Phase 0/2 PD-Trigger Study of BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors Glioblastoma (GBM) | EARLY_Phase 1 | 2026-04-01 |
| Recruiting | A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (AD Glioblastoma (GBM), Brain Metastasases | EARLY_Phase 1 | 2026-02-11 |
| Active Not Recruiting | Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Glioblastoma WHO Grade IV | EARLY_Phase 1 | 2025-09-04 |
| Recruiting | Clinical Trial of BMS-986504 in Recurrent GBM Patients Glioblastoma WHO Grade IV | EARLY_Phase 1 | 2025-04-28 |
| Recruiting | Abemaciclib in Newly Diagnosed Meningioma Patients Meningioma | Phase 2 | 2025-03-24 |
| Recruiting | Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG High Grade Glioma, Glioma, Glioma, Malignant | EARLY_Phase 1 | 2023-05-15 |
| Active Not Recruiting | AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients Glioblastoma, Glioma, Glioblastoma Multiforme | EARLY_Phase 1 | 2022-05-27 |
| Active Not Recruiting | Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma Glioblastoma, Glioblastoma Multiforme, Glioma | EARLY_Phase 1 | 2021-10-29 |
| Recruiting | Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma High Grade Glioma | EARLY_Phase 1 | 2021-03-15 |
| Active Not Recruiting | Study of Pamiparib in Newly Diagnosed and rGBM Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult | EARLY_Phase 1 | 2021-01-11 |
| Terminated | Infigratinib in Recurrent High-Grade Glioma Patients Glioma, Glioblastoma, GBM | EARLY_Phase 1 | 2020-07-21 |
| Completed | LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients Glioblastoma, GBM, Glioma | EARLY_Phase 1 | 2020-07-11 |
| Active Not Recruiting | Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients Glioblastoma Multiforme, Meningioma | EARLY_Phase 1 | 2016-10-17 |